Equity-Based Compensation (Schedule Of Stock Appreciation Rights Activity) (Details) - Stock Appreciation Rights (SARs) $ / shares in Units, $ in Thousands	12 Months Ended
	Oct. 03, 2020 USD ($) $ / shares shares
Share-based Compensation Arrangement by Share-based Payment Award, Non-Option Equity Instruments, Outstanding [Roll Forward]
SARs, Outstanding, Beginning of period | shares	935,156
SARs, Granted | shares	136,700
SARs, Exercised | shares	(71,557)
SARs, Expired | shares	(6,599)
SARs, Forfeited | shares	(9,430)
SARs, Outstanding, End of period | shares	984,270
SARs, Exercisable | shares	740,288
SARs, Weighted Average Exercise Price, Beginning of period | $ / shares	$ 62.60
SARs, Weighted Average Exercise Price, Granted | $ / shares	85.95
SARs, Weighted Average Exercise Price, Exercised | $ / shares	41.77
SARs, Weighted Average Exercise Price, Expired | $ / shares	75.58
SARs, Weighted Average Exercise Price, Forfeited | $ / shares	83.20
SARs, Weighted Average Exercise Price, End of period | $ / shares	67.07
SARs, Weighted Average Exercise Price, Exercisable | $ / shares	$ 61.63
SARs, Weighted Average Remaining Contractual Terms, Outstanding	5 years
SARs, Weighted Average Remaining Contractual Terms, Exercisable	3 years 9 months 18 days
SARs, Aggregate Intrinsic Value, Outstanding | $	$ 6,777
SARs, Aggregate Intrinsic Value, Exercisable | $	$ 6,777